Clinical Trials on Contrast Agent in Australia
Total 27 results
-
Medical University of ViennaCompletedVisual Acuity | Lenses, Intraocular | Contrast SensitivityAustria
-
Medical University of ViennaCompleted
-
Clinuvel Pharmaceuticals LimitedCompletedPolymorphic Light Eruption (PLE)Austria, Australia, United Kingdom
-
Azura OphthalmicsAvaniaCompletedContact Lens DiscomfortAustralia
-
Wilhelminenspital ViennaAkron Molecules AGCompletedAnalgesic Drugs | Antinociceptive AgentsAustria
-
The University of New South WalesCompletedContact Lens DiscomfortAustralia
-
Medical University of GrazAbbott Diagnostics DivisionCompletedContrast Media Induced Nephropathy (CIN)Austria
-
Medical University of GrazCompletedEarly Skin-to-skin ContactAustria
-
Medical University of ViennaUnknownGd-based Contrast Media Exposure During Breast MRI ScansAustria
-
Medical University InnsbruckRecruitingChemotherapeutic Toxicity | Chemotherapy-induced Peripheral Neuropathy | Chemotherapeutic Agent ToxicityAustria
-
Azura OphthalmicsThe University of New South WalesCompletedMeibomian Gland Dysfunction (MGD) | Contact Lens Discomfort (CLD)Australia
-
Medical University of ViennaRecruitingContact Lens | Tear Film ThicknessAustria
-
The University of QueenslandUnknownAntifungal AgentsBelgium, Spain, Finland, United States, Australia, Canada, France, Greece, Hong Kong, Italy, Malaysia, Netherlands, Portugal
-
BayerCompletedContrast MediaUnited States, Germany, Italy, Korea, Republic of, Austria, Thailand, Australia, Spain, United Kingdom
-
Medical University of GrazCompletedPulmonary Hypertension | Ventricular Function | MR Phase Contrast Velocity Imaging | Late Enhancement PatternsAustria
-
Medicines for Malaria VentureGlaxoSmithKline; ICON plc; QIMR Berghofer Medical Research Institute; Swiss BioQuant... and other collaboratorsCompletedPathologic Processes | Infections | Systemic Inflammatory Response Syndrome | Inflammation | Vector Borne Diseases | Parasitic Diseases | Protozoan Infections | Malaria | Parasitemia | Malaria,Falciparum | Anti-Infective Agents | AntimalarialsAustralia
-
Osprey Medical, IncCompletedContrast Induced Nephropathy (CIN)United States, New Zealand, Australia
-
Medical University of GrazCompletedPregnancy Related | Cesarean Section; Complications | Adverse Reaction to Oxytocic AgentsAustria
-
Medical University of GrazCompleted
-
Medical University of GrazAustrian Science Fund (FWF)TerminatedPolymorphic Light EruptionAustria
-
Medical University of GrazCompletedPolymorphic Light EruptionAustria
-
Medical University of GrazRecruiting
-
Medical University of GrazCompletedPsoriasis | Atopic Eczema | Polymorphic Light EruptionAustria
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Extragonadal Germ Cell Tumor | Childhood Germ Cell Tumor | Drug/Agent Toxicity by Tissue/OrganUnited States, Canada, Netherlands, Puerto Rico, Switzerland, Australia
-
Eli Lilly and CompanyActive, not recruitingUrogenital Neoplasms | Prostatic Neoplasms | Neoplasm Metastasis | Enzyme Inhibitors | Antineoplastic Agents | Hormones | Physiological Effects of Drugs | Antineoplastic Agents, Hormonal | Androgens | Hormones, Hormone Substitutes, and Hormone Antagonists | Abiraterone Acetate | Steroid Synthesis Inhibitors | Cytochrome... and other conditionsChina, Canada, France, United States, Australia, Czechia, Hungary, Spain, Germany, Japan, Taiwan, Netherlands, Mexico, Belgium, Korea, Republic of, Turkey, Argentina, Romania, United Kingdom, Italy, Israel, Brazil, Poland, Greece
-
Novartis PharmaceuticalsCompletedParkinson Disease | Parkinsonian Disorders | Movement Disorders | Dyskinesias | Anti-Dyskinesia AgentsSpain, United States, Austria, Switzerland, France, Germany, Italy, Canada, Hungary, Slovakia
-
Novartis PharmaceuticalsCompletedParkinson Disease | Parkinsonian Disorders | Movement Disorders | Dyskinesias | Anti-Dyskinesia AgentsSpain, United States, Austria, Switzerland, France, Germany, Italy, Hungary, Canada, Slovakia